Teva Pharmaceutical Industries (TEVA)

Create an Alert
39.73 +0.41  +1.04%   NYSE Jun 18, 5:00PM BATS Real time Currency in USD

Teva Pharmaceutical Industries Cash from Operations Quarterly:

1.102B for March 31, 2013
View Full Chart

Teva Pharmaceutical Industries Cash from Operations Quarterly Chart

    Teva Pharmaceutical Industries Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.102B
    Dec. 31, 2012 1.577B
    Sept. 30, 2012 1.048B
    June 30, 2012 1.191B
    March 31, 2012 756.00M
    Dec. 31, 2011 1.428B
    Sept. 30, 2011 482.00M
    June 30, 2011 1.324B
    March 31, 2011 900.00M
    Dec. 31, 2010 1.102B
    Sept. 30, 2010 1.194B
    June 30, 2010 954.00M
    March 31, 2010 886.00M
    Dec. 31, 2009 957.00M
    Sept. 30, 2009 1.025B
    June 30, 2009 658.00M
    March 31, 2009 733.00M
    Dec. 31, 2008 969.00M
    Sept. 30, 2008 710.00M
    June 30, 2008 806.00M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    TEVA Cash from Operations Quarterly Benchmarks

    Companies
    Pfizer 2.241B
    Actavis 218.60M
    Mylan 87.56M

    TEVA Cash from Operations Quarterly Rankings

    Overall 98th percentile
    194 of 16773
    Sector 99th percentile
    14 of 1408 in Healthcare
    Industry 99th percentile
    1 of 152 in Drug Manufacturers - Specialty & Generic

    TEVA Cash from Operations Quarterly Range, Past 5 Years

    Minimum 482.00M Sep 2011
    Maximum 1.577B Dec 2012
    Average 990.10M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');